A Lump Found in the Shower at Thirty-Eight: Triple Assessment of a Palpable Breast Mass, Imaging Chosen by Appropriateness Criteria and a Plan That Does Not Stop at a Negative Mammogram
[Student Name]
University of Phoenix
NRP/563: Management of Women's Health Issues
Week 8 Assignment
[Instructor Name]
[Date]
The patient is a composite written for a model paper.
Ms. N., a 38-year-old paralegal, found a lump in her left breast in the shower a week ago. It is not painful. She has not noticed skin changes or nipple discharge. Her periods are regular, and her last period ended five days ago. Her mother's sister had breast cancer at 62. She has never had a mammogram. This paper describes the evaluation.
The Clinical Breast Examination
With Ms. N. seated and then lying down, I inspect for asymmetry, skin dimpling, nipple retraction and redness, then palpate each breast systematically in vertical strips with varying pressure, including the axillae and supraclavicular areas. In the upper outer quadrant of the left breast, at the 2 o'clock position about 6 cm from the nipple, I feel a 1.5 cm mass that is firm, somewhat irregular and less mobile than surrounding tissue. The right breast and both axillae are normal.
What the Examination Can Tell
Barton et al. (1999) reviewed the clinical breast examination and estimated a sensitivity of 54% and a specificity of 94% in screening, concluding that although the examination by itself does not rule out disease, the high specificity of certain abnormal findings greatly increases the probability of breast cancer. Features that raise concern include hardness, irregular borders, fixation, skin or nipple changes and associated lymph nodes. Ms. N.'s mass is firm, irregular and less mobile, features that increase suspicion.
The examination cannot tell me what the lump is, but it can tell me not to let the next test be the last one.
Choosing Imaging
The ACR Appropriateness Criteria for palpable breast masses recommend imaging by age: for women 40 and older, diagnostic mammography, usually with ultrasound; for women 30 to 39, diagnostic mammography or ultrasound are both appropriate initial studies, often combined; and for women under 30, ultrasound first (Moy et al., 2017). At 38, Ms. N. has diagnostic mammography with targeted ultrasound of the palpable area, scheduled within a week.
Interpreting the Results
The imaging report uses a standardized assessment category. If ultrasound shows a simple cyst, it is benign and no further action is needed. If it shows a solid mass with benign features, short-interval follow-up or biopsy may be recommended depending on features and patient preference. If it shows suspicious features, core needle biopsy is recommended.
The Rule About Negative Imaging
Pruthi (2001) emphasizes that a palpable breast mass requires definitive evaluation and that negative mammography should not end the workup of a clinically suspicious mass, because mammography can miss cancers, particularly in dense breast tissue common in younger women. The ACR criteria similarly note that a suspicious clinical finding should prompt biopsy even when imaging is negative (Moy et al., 2017). I explain this to Ms. N. before the test, so she understands that a normal mammogram alone will not end the evaluation.
Her Results
Her mammogram shows dense breast tissue without a clear abnormality. Ultrasound shows a 1.4 cm solid, irregular, hypoechoic mass with indistinct margins, assessed as suspicious. A core needle biopsy is scheduled.
Why Timing in the Cycle Matters
Breast tissue changes during the menstrual cycle, and some lumps that are hormonally driven shrink after a period. Ms. N.'s examination took place five days after her period ended, when breast tissue is least nodular, so the finding is unlikely to be cyclical change. For vague thickening rather than a discrete mass, re-examination after the next period is sometimes reasonable; a discrete, firm, irregular mass like hers should not wait.
Why Ultrasound Added So Much
In dense breast tissue, cancers can be hidden on mammography because both appear white. Ultrasound distinguishes solid from cystic masses and shows margins and shape, which is why the criteria combine it with mammography for women in their thirties (Moy et al., 2017). Her mammogram alone would have been falsely reassuring.
The Core Needle Biopsy
Core needle biopsy, guided by ultrasound, removes small cylinders of tissue through a needle under local anesthesia and allows a pathologist to diagnose cancer or a benign lesion. It avoids surgery for most benign masses and guides surgical planning if cancer is found. Pathology results must match the imaging findings; if a benign result does not explain a suspicious image, further sampling is needed.
Supporting Her
Waiting for a biopsy is frightening. I call her with the ultrasound result the same day, explain what it means and what it does not mean yet, arrange the biopsy quickly and provide a nurse navigator's contact. Most breast biopsies show benign disease, but I do not offer false reassurance.
Family History
Her aunt's breast cancer at 62, a second-degree relative diagnosed after menopause, is not, on its own, enough to trigger genetic testing, but I will reassess her family history in detail and use a risk model after the biopsy result.
Completing Her Well-Woman Care
While addressing the lump, I also update her other preventive care: cervical screening is current; blood pressure and lipids are normal; she receives an influenza vaccine; and we discuss when routine screening mammography should begin, which would be at 40 or earlier depending on the biopsy result and risk assessment.
If the Biopsy Is Benign
If the biopsy shows a benign lesion, such as a fibroadenoma, and the pathology fits the imaging, she will have follow-up imaging at intervals set by the radiologist. If pathology and imaging do not match, the lesion will be sampled again or removed.
If the Biopsy Shows Cancer
If the biopsy shows cancer, she will be referred promptly to a breast surgeon and a multidisciplinary team, and genetic counseling will be offered based on her age at diagnosis and family history.
Communicating Results
I tell Ms. N. exactly when and how she will receive the biopsy result, by an in-person visit rather than a portal message, so that she is not left reading a pathology report alone.
Her Support
She will bring her sister to the biopsy appointment, and the nurse navigator will call her the day before to explain what to expect.
Breast Awareness
Ms. N. found the lump herself. I encourage her to remain familiar with how her breasts normally look and feel and to report changes promptly, without imposing a rigid monthly routine.
Follow-Up
I will review the biopsy result with her in person and coordinate referral to a breast surgeon if needed.
Conclusion
Ms. N.'s firm, irregular, less mobile breast mass was examined systematically, and its features raised suspicion despite the limited sensitivity of the clinical examination. Imaging followed the ACR criteria for her age, and when ultrasound showed a suspicious solid mass in dense breasts where mammography was unrevealing, she was scheduled for biopsy. The plan followed the principle that a suspicious palpable mass must be resolved by tissue, not dismissed by a negative image.
References
Barton, M. B., Harris, R., & Fletcher, S. W. (1999). Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA, 282(13), 1270-1280. https://doi.org/10.1001/jama.282.13.1270
Moy, L., Heller, S. L., Bailey, L., D'Orsi, C., DiFlorio, R. M., Green, E. D., Holbrook, A. I., Lee, S.-J., Lourenco, A. P., Mainiero, M. B., Sepulveda, K. A., Slanetz, P. J., Trikha, S., Yepes, M. M., & Newell, M. S. (2017). ACR Appropriateness Criteria palpable breast masses. Journal of the American College of Radiology, 14(5S), S203-S224. https://doi.org/10.1016/j.jacr.2017.02.033
Pruthi, S. (2001). Detection and evaluation of a palpable breast mass. Mayo Clinic Proceedings, 76(6), 641-648. https://doi.org/10.4065/76.6.641
How this NRP 563 Week 8 example is structured
The NRP/563 Week 8 work usually closes with breast health and a comprehensive women's health case. This paper follows a palpable mass through examination, imaging and the decision about biopsy, emphasizing the rule that a suspicious lump must be resolved and not dismissed by a single negative test. Students search this week as NRP 563 Week 8, NRP563 Wk 8 or NRP/563 Wk 8; all three are the same assignment.
NRP/563 Week 8 questions, answered
What does NRP/563 Week 8 usually ask for?
Many sections close with breast health or a comprehensive women's health case, integrating screening, examination, diagnostic workup and preventive care.
What imaging is used for a breast lump in a woman in her thirties?
The ACR Appropriateness Criteria support diagnostic mammography with ultrasound, or ultrasound first, for women aged 30 to 39, with ultrasound usually first for women under 30.
Can a negative mammogram rule out cancer in a palpable lump?
No. A clinically suspicious mass needs further evaluation, often biopsy, even if imaging is negative, because mammography can miss cancers, especially in dense breasts.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.